TechTalk: Crucial Starting Material Considerations for NAM Success
Friday, September 25 at 16:00 BST | 17:00 CEST | 11:00 EDT | 08:00 PDT
With industry and regulatory leaders alike calling for New Approach Methodologies (NAMs) that provide reproducible nonclinical data that more accurately represents human biology, this presentation explores the critical role of human specimen starting materials in the success of NAMs and how ethical sourcing, characterization, and quality control can drive confidence, reproducibility, and regulatory acceptance.
Certificate of attendance
If you attend the live TechTalk, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes. If you view the on-demand TechTalk, you can request a certificate of attendance by emailing editor@selectscience.net.
TechTalk details
- Cost: Free to attend
- Location: Online
- Duration: 20 minutes
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on-demand recording once it becomes available.
Speakers
Who should attend?
- Anyone looking to develop &/or implement NAMs in their research or drug development program
Featured products
Request Quote for All Products
Clinically-Collected Specimens
BioIVTBioIVT has the expertise in the processes required for ethical acquisition of biospecimens that cover a wide range of disease states and the protocols needed to produce reliable data. With over 425 IRB-approved clinical sites, BioIVT provides clinical specimens for nearly all disease states.
Isolated Immune Cells
BioIVTIsolated immune cells play a crucial role across the stages of drug discovery and development from biomarker and target identification through screening and safety assessment to manufacturing. They can be used to create disease models, cell lines, gene editing techniques and more.
Visionaire Biospecimen and Clinical Data
BioIVTAccess 30+ years of BioIVT’s vast biobank collections’ clinical data, biospecimen imaging and biomarker findings. Delve into AI-ready datasets for oncology, neurology and more that meet regulatory requirements, ethical standards and privacy laws.
What will this webinar cover?
- How to manage donor variability while maintaining human relevance and reproducibility
- The importance of fit‑for‑purpose QC, standardization, and documentation
- Biospecimen considerations to de‑risk NAM development from the start